Cargando…
Development of a Metastasis-Related Immune Prognostic Model of Metastatic Colorectal Cancer and Its Usefulness to Immunotherapy
Background: Post-surgical recurrence of the metastatic colorectal cancer (mCRC) remains a challenge, even with adjuvant therapy. Moreover, patients show variable outcomes. Here, we set to identify gene models based on the perspectives of intrinsic cell activities and extrinsic immune microenvironmen...
Autores principales: | Luo, Zhiwen, Chen, Xiao, Zhang, Yefan, Huang, Zhen, Zhao, Hong, Zhao, Jianjun, Li, Zhiyu, Zhou, Jianguo, Liu, Jianmei, Cai, Jianqiang, Bi, Xinyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876250/ https://www.ncbi.nlm.nih.gov/pubmed/33585439 http://dx.doi.org/10.3389/fcell.2020.577125 |
Ejemplares similares
-
From the completion of neoadjuvant chemotherapy to surgery for colorectal cancer liver metastasis: What is the optimal timing?
por: Chen, Qichen, et al.
Publicado: (2020) -
The prognostic factors of primary colorectal sarcoma and the clinical outcomes of negative lymph node dissection
por: Wei, Zhewen, et al.
Publicado: (2021) -
Simultaneous hepatic resection benefits patients with synchronous colorectal cancer liver metastases
por: Li, Yuan, et al.
Publicado: (2016) -
Differences of intraoperative outcomes and postoperative complications between intrahepatic cholangiocarcinoma and colorectal liver metastasis in different surgical methods
por: Chen, Qichen, et al.
Publicado: (2021) -
What is the optimal number of neoadjuvant chemotherapy cycles for resectable colorectal liver oligometastases?
por: Chen, Qichen, et al.
Publicado: (2021)